Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MITE: Compound Azintamide for Post-Cholecystectomy Dyspepsia
NCT04786795Phase 4Unknown
- Sponsor
- Xinhua Hospital
- Start
- Mar 2021
- Primary completion
- Feb 2022
01
Overview
A Phase 4 trial of compound azintamide enteric-coated tablets in dyspepsia, sponsored by Xinhua Hospital. Status: unknown.
02
Drugs
compound azintamide enteric-coated tablets
03
Conditions
dyspepsia
Beyond the preview
Go deeper on NCT04786795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04786795.